5-hydrosulfonyl-N,N-dimethylnaphthalen-1-amine

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 5-hydrosulfonyl-N,N-dimethylnaphthalen-1-amine
• 化学式: C₁₂H₁₃NO₂S
• 分子量: 235.3
• InChiKey: YGZQFKWCXPKZSE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  38.4
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• AMINE-DERIVATIVES HAVING NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY AND THE USES THEREOF
  申请人：OKUNO Takayuki

  公开号：US20100273841A1

  公开（公告）日：2010-10-28

  This invention provides an anorectic or anti-obesity composition comprising a compound of the formula (I): formula (I): a pharmaceutically acceptable salt or solvate thereof, wherein R 1 is optionally substituted lower alkyl, Y is —S(O)n- wherein n is 1 or 2, or —CO—, R 2 is hydrogen or lower alkyl, R 7 is hydrogen or lower alkyl, X is lower alkylene, lower alkenylene, arylene, cycloalkylene or the like, and Z is lower alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl or the like.

  本发明提供了一种厌食剂或抗肥胖组合物，包括公式(I)的化合物： 公式(I)： 其药用可接受的盐或溶剂化物， 其中 R1是可选地取代的低级烷基， Y是—S(O)n—，其中n是1或2，或者—CO—， R2是氢或低级烷基， R7是氢或低级烷基， X是低级亚烷基，低级亚烯基，芳基，环烷基或类似物， Z是低级烷基，可选地取代的碳环烷基，可选地取代的杂环烷基或类似物。
• 1-(SULFONYL)-N-PHENYLPYRROLIDINE-2-CARBOXAMIDES FOR THE IDENTIFICATION OF BIOLOGICAL AND PHARMACOLOGICAL ACTIVITY
  申请人：Castells Boliart Josep

  公开号：US20120142936A1

  公开（公告）日：2012-06-07

  Novel compounds are continually sought after to treat and prevent diseases and disorders. The invention relates to 1-(sulfonyl)-N-phenylpyrrolidine-2-carboxamides which are useful for being biologically and pharmacologically screened, and to contribute to the exploration and identification of new lead molecules that are capable of modulating the functional activity of a biological target.

  小说化合物不断被寻求用于治疗和预防疾病和紊乱。该发明涉及对1-(磺酰基)-N-苯基吡咯烷-2-羧酰胺的利用，这些化合物有助于进行生物学和药理学筛选，并有助于探索和鉴定能够调节生物靶标功能活性的新引物分子。
• DERIVATIVES OF 4-AMINOPIPERIDINE AND THEIR USE AS A MEDICAMENT
  申请人：THURIEAU Christophe

  公开号：US20110059971A1

  公开（公告）日：2011-03-10

  A subject of the present application is new derivatives of 4-aminopiperidines of formula in which R 1 , R 2 and R 3 represent various radical, and their preparation processes by synthetic methods in parallel in liquid and solid phase. These products having a good affinity with certain sub-types of somatostatin receptors, they are particularly useful for treating the pathological states or diseases in which one (or more) somatostatin receptors are involved.

  本申请的主题是公式中R1、R2和R3代表不同基团的新型4-氨基哌啶衍生物及其在液态和固态平行合成方法中的制备过程。这些产物与某些生长抑素受体的亚型具有良好的亲和力，特别适用于治疗某些病理状态或疾病，其中涉及一个（或多个）生长抑素受体。
• CONDUCTING AND SEMI-CONDUCTING ALIGNMENT MATERIALS
  申请人：ROLIC AG

  公开号：US20160276592A1

  公开（公告）日：2016-09-22

  The invention relates to conducting and semi-conducting photoreactive compounds, represented by the general formula (I), to the use of these compounds for the preparation of oriented and/or orientation layers; and to their use in the construction of unstructured and structured optical, electro optical or optoelectronic elements and multi-layer systems.

  该发明涉及具有导电和半导体光反应化合物，其通式表示为(I)，以及使用这些化合物制备定向和/或定向层的方法；以及它们在构建非结构化和结构化光学、电光或光电元件和多层系统方面的应用。
• Fluorescence-Labelled Fatty Acids and Uses Thereof
  申请人：SANOFI

  公开号：US20150285812A1

  公开（公告）日：2015-10-08

  The present invention relates to a composition comprising (i) a fluorescent-labelled fatty acid and (ii) a fatty acid binding compound, wherein (a) the fatty acid component of the fluorescent-labelled fatty acid binds the fatty acid binding compound and (b) the fluorescent component of the fluorescent-labelled fatty acid and the fatty acid binding compound interact to elicit FRET (Förster resonance energy transfer) effects. Moreover, the invention is directed to a method for identifying and/or characterizing a compound of interest by contacting a fluorescent-labelled fatty acid with a fatty acid binding compound under conditions that allow for binding and for FRET (Förster resonance energy transfer) effects, and then contacting the fluorescent-labelled fatty acid bound to the fatty acid binding compound with a compound of interest and determining the change in fluorescence. In addition, the invention pertains to corresponding kits of parts and uses of the compositions and methods.

  本发明涉及一种组合物，包括（i）一种荧光标记的脂肪酸和（ii）一种脂肪酸结合化合物，其中（a）荧光标记的脂肪酸的脂肪酸成分结合脂肪酸结合化合物，（b）荧光标记的脂肪酸的荧光成分和脂肪酸结合化合物相互作用，以引发FRET（Förster共振能量转移）效应。此外，本发明还涉及一种方法，通过在允许结合和FRET（Förster共振能量转移）效应的条件下，将荧光标记的脂肪酸与脂肪酸结合化合物接触，然后将荧光标记的脂肪酸与感兴趣的化合物结合，并测定荧光的变化来识别和/或表征感兴趣的化合物。此外，本发明还涉及相应的部件套件和组合物和方法的用途。